NCT00715637 · Interventional trial
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
Overall registry status Unknown
Phase 3
Conditions Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory